Skip to content

Daniel Toker, PhD

Neuroscientist at UCLA

  • Home
  • About
  • Blog
  • Publications
  • Podcast
  • TV/Media
  • Instagram
  • TikTok
  • Resources for Aspiring scientists

Recent Posts

  • The Search for a Cure for Coma
  • The Brain Scientists of the Qing Dynasty
  • Can Life Produce Chaos?
  • Elitism is a Threat to Science
  • You Don’t Have a Lizard Brain
danieltoker@g.ucla.edu

Tag: fukuyama

The Ethics of Cognitive Enhancement: Part 3

Go back to Part 1. Go back to Part 2. From the discussion in the last two parts of this series on the ethics of cognitive enhancement, we can draw three conclusions. The first is that we should allow all forms of cognitive alterations that aren’t lethal and don’t lead you to harm others. As […]

Read More The Ethics of Cognitive Enhancement: Part 3

The Ethics of Cognitive Enhancement: Part 2

Go back to Part 1.  In Part 1 of this series on the ethics of cognitive enhancement, I pointed out that it is not logical to deny people access to new methods of cognitive enhancement as they become available, because such methods would not be categorically different from methods of cognitive enhancement that are currently legal and […]

Read More The Ethics of Cognitive Enhancement: Part 2

The Ethics of Cognitive Enhancement: Part 1

“Smart drugs” like Adderall and Modafinil are just the beginning of the cognitive enhancement revolution. Though they were initially developed to alleviate the symptoms of cognitive disorders, these and similar drugs are increasingly being used by the cognitively healthy to boost memory, focus, and wakefulness over long periods of work. With the commercial use of […]

Read More The Ethics of Cognitive Enhancement: Part 1
WordPress.com.
 

Loading Comments...